FdaApplication
ANDA 204872
Identifiers
- fda_app_no: ANDA204872
Properties
| Property | Value |
|---|---|
| applicant_name | LNK INTERNATIONAL INC |
| application_type | ANDA |
| approval_date | 2017-01-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET;ORAL |
1 product